FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377356001: Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2639000014 Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2642979011 Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml Is a Diphtheria vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml Is a Tetanus vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml Is a Haemophilus influenzae Type b vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetanus toxoid false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Influenza virus vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Haemophilus influenzae type b vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml Is a Diphtheria + tetanus + haemophilus influenzae type b vaccine false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml Has manufactured dose form Injection false Inferred relationship Some
    Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start